Enzalutamide

CHEMBL1082407 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

464.4 g/mol

LogP

3.6

Phase

4

This medication blocks androgen receptors so that male hormones cannot stimulate the growth of prostate cancer cells. It is used to treat advanced prostate cancer that continues to grow despite other hormonal treatments.

Masse moléculaire

464,4000 g/mol

LogP

3,60

TPSA

109,00 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Pain Management Non-Small Cell Lung Cancer Epilepsy Melanoma Lymphoma Hypertension Breast Cancer Chronic Pain Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F

InChI

InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)

Molecular Formula

C21H16F4N4O2S

HBD / HBA

1 / 8

Liaisons Rotatives

3

Atomes Lourds

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This medication blocks androgen receptors so that male hormones cannot stimulate the growth of prostate cancer cells. It is used to treat advanced prostate cancer that continues to grow despite other hormonal treatments.

Yes, Enzalutamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1082407. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 15951529. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Enzalutamide sur PillFYI

Structure

Données Clés

Formule: C21H16F4N4O2S
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.